$0.07
0.00%
Nasdaq, Wed, Dec 24 2025
ISIN
US4268971045
Symbol
HEPA
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals

Hepion Pharmaceuticals Inc Stock News

Neutral
GlobeNewsWire
●
6 months ago
Hepion Pharmaceuticals Successfully Completes Application to the OTCQB
MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), helicobacter pylori (H.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today